Background: The aim of this study was to compare arterial embolization (AE) with portal vein embolization (PVE) for the induction of segmental hypertrophy regarding procedural efficacy, safety and outcome. Methods: A total of 29 mini pigs were subjected to PVE, AE or assigned to the sham (SO) group. Correspondingly, 75% of the hepatic artery or portal vein branches were embolized. Growth and atrophy of the liver lobes, calculating the liver-to-body weight index (LBWI), laboratory data, arteriography, portography, Doppler ultrasound (US) and histopathology were analyzed. Results: After PVE, 2 animals had to be excluded due to technical problems. After AE, 4 animals had to be excluded because of technical problems and early sacrifice. Postprocedural US demonstrated effective AE and PVE of the respective lobes. Four weeks after PVE, portography showed a slow refilling of the embolized lobe by collateral portal venous vessels. Four weeks after AE, arteriography revealed a slight revascularization of the embolized lobes by arterial neovascularization. Segmental AE led to extensive necrotic and inflammatory alterations in the liver and bile duct parenchyma. Significant hypertrophy of the non-embolized lobe was only noted in the PVE group (LBWI: 0.91 ± 0.28%; p = 0.001). There was no increase in the non-embolized lobe in the AE (LBWI: 0.45 ± 0.087%) and SO group (LBWI: 0.45 ± 0.13%). Conclusion: PVE is safe and effective to induce segmental hypertrophy. Portal reperfusion by collateral vessels may limit hypertrophy. AE did not increase the segmental hepatic volume but carries the risk of extensive necrotic inflammatory damage.

1.
Abulkhir A, Limongelli P, Healey AJ, Damrah O, Tait P, Jackson J, Habib N, Jiao LR: Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008;247:49-57.
2.
Chen MF, Hwang TL, Hung CF: Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography. Ann Surg 1991;213:227-229.
3.
Elias D, Ouellet JF, De Baere T, Lasser P, Roche A: Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 2002;131:294-299.
4.
Vogl TJ, Zangos S, Balzer JO, Nabil M, Rao P, Eichler K, Bechstein WO, Zeuzem S, Abdelkader A: Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results (in German). Rofo 2007;179:1113-1126.
5.
Vogl TJ, Balzer JO, Dette K, Hintze R, Pegios W, Maurer J, Keck H, Neuhaus P, Felix R: Initially unresectable hilar cholangiocarcinoma: hepatic regeneration after transarterial embolization. Radiology 1998;208:217-222.
6.
Denecke T, Seehofer D, Steffen IG, Grieser C, Stelter L, Schnapauff D, Rothe JH, Weigelt A, Pech M, Langrehr J, Podrabsky P, Neuhaus P, Hanninen EL: Arterial versus portal venous embolization for induction of hepatic hypertrophy before extended right hemihepatectomy in hilar cholangiocarcinomas: a prospective randomized study. J Vasc Interv Radiol 2011;22:1254-1262.
7.
Bloechle C, Emmermann A, Strate T, Scheurlen UJ, Schneider C, Achilles E, Wolf M, Mack D, Zornig C, Broelsch CE: Laparoscopic vs open repair of gastric perforation and abdominal lavage of associated peritonitis in pigs. Surg Endosc 1998;12:212-218.
8.
Wilms C, Mueller L, Lenk C, Wittkugel O, Helmke K, Krupski-Berdien G, Rogiers X, Broering DC: Comparative study of portal vein embolization versus portal vein ligation for induction of hypertrophy of the future liver remnant using a mini-pig model. Ann Surg 2008;247:825-834.
9.
Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, Hayakawa N, Yamamoto H: Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995;21:434-439.
10.
Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, Yamazaki S, Hasegawa H, Ozaki H: Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107:521-527.
11.
Ogasawara K, Uchino J, Une Y, Fujioka Y: Selective portal vein embolization with absolute ethanol induces hepatic hypertrophy and makes more extensive hepatectomy possible. Hepatology 1996;23:338-345.
12.
Hayashi H, Beppu T, Sugita H, Masuda T, Okabe H, Takamori H, Baba H: Serum HGF and TGF-beta1 levels after right portal vein embolization. Hepatol Res 2010;40:311-317.
13.
Kusaka K, Imamura H, Tomiya T, Takayama T, Makuuchi M: Expression of transforming growth factor-alpha and -beta in hepatic lobes after hemihepatic portal vein embolization. Dig Dis Sci 2006;51:1404-1412.
14.
Goto Y, Nagino M, Nimura Y: Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization. Ann Surg 1998;228:209-213.
15.
Kin Y, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, Miyachi M, Kanai M: Doppler analysis of hepatic blood flow predicts liver dysfunction after major hepatectomy. World J Surg 1994;18:143-149.
16.
Mueller L, Broering DC, Meyer J, Vashist Y, Goettsche J, Wilms C, Rogiers X: The induction of the immediate-early-genes Egr-1, PAI-1 and PRL-1 during liver regeneration in surgical models is related to increased portal flow. J Hepatol 2002;37:606-612.
17.
Um SH, Nishida O, Tokubayashi M, Kimura F, Takimoto Y, Yoshioka H, Inque R, Kita T: Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction. Hepatology 1994;19:202-209.
18.
Kito Y, Nagino M, Nimura Y: Doppler sonography of hepatic arterial blood flow velocity after percutaneous transhepatic portal vein embolization. AJR Am J Roentgenol 2001;176:909-912.
19.
Rocheleau B, Ethier C, Houle R, Huet PM, Bilodeau M: Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis. Am J Physiol 1999;277:G1000-G1007.
20.
Kollmar O, Corsten M, Scheuer C, Vollmar B, Schilling MK, Menger MD: Portal branch ligation induces a hepatic arterial buffer response, microvascular remodeling, normoxygenation, and cell proliferation in portal blood-deprived liver tissue. Am J Physiol Gastrointest Liver Physiol 2007;292:G1534-G1542.
21.
Michalopoulos GK, DeFrances M: Liver regeneration. Adv Biochem Eng Biotechnol 2005;93:101-134.
22.
Rozga J, Jeppsson B, Bengmark S: Portal branch ligation in the rat. Reevaluation of a model. Am J Pathol 1986;125:300-308.
23.
Weinbren K, Stirling GA, Washington SL: The development of a proliferative response in liver parenchyma deprived of portal blood flow. Br J Exp Pathol 1972;53:54-58.
24.
Lautt WW: Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985;249:G549-G556.
25.
Rous P, Larimore LD: Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med 1920;31:609-632.
26.
Kaman J: A study of the plasticity of the arterial flow bed of pig's liver following partial or complete ligation of the hepatic artery (in German). Gegenbaurs Morphol Jahrb 1967;110:390-421.
27.
Krupski G, Broring DC, Wittkugel O, Muller L, Nicolas V, Rogiers X, Adam G, Bucheler E: Formation of portal venous collaterals after ligation of the portal vein for induction of liver regeneration (in German). Rofo 2002;174:1281-1284.
28.
Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Horbelt R, Kroemer A, Loss M, Rummele P, Scherer MN, Padberg W, Konigsrainer A, Lang H, Obed A, Schlitt HJ: Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 2012;255:405-414.
29.
Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, Kokudo N, Makuuchi M: Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 2004;139:766-774.
30.
Kokudo N, Makuuchi M: Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin North Am 2004;84:643-657.
31.
Arii S, Okamoto E, Imamura M: Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan. Semin Surg Oncol 1996;12:204-211.
32.
Nagino M, Nimura Y, Kamiya J, Kanai M, Hayakawa N, Yamamoto H: Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration. AJR Am J Roentgenol 1998;171:1037-1039.
33.
Madoff DC, Gupta S, Pillsbury EP, Kan Z, Tinkey PT, Stephens LC, Ensor JE, Hicks ME, Wright KC: Transarterial versus transhepatic portal vein embolization to induce selective hepatic hypertrophy: a comparative study in swine. J Vasc Interv Radiol 2007;18:79-93.
34.
Cheng Y, Kan Z, Chen C, Huang T, Chen T, Yang B, Ko S, Lee T: Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: clinical study. World J Surg 2000;24:844-850; discussion 850.
35.
Edeline J, Lenoir L, Boudjema K, Rolland Y, Boulic A, Le Du F, Pracht M, Raoul JL, Clement B, Garin E, Boucher E: Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Ann Surg Oncol 2013;20:2518-2525.
36.
Fernandez-Ros N, Silva N, Bilbao JI, Inarrairaegui M, Benito A, D'Avola D, Rodriguez M, Rotellar F, Pardo F, Sangro B: Partial liver volume radioembolization induces hypertrophy in the spared hemiliver and no major signs of portal hypertension. HPB (Oxford) 2014;16:243-249.
37.
Teo JY, Goh BK, Cheah FK, Allen JC, Lo RH, Ng DC, Goh AS, Khor AY, Sim HS, Ng JJ, Chow PK: Underlying liver disease influences volumetric changes in the spared hemiliver after selective internal radiation therapy with 90y in patients with hepatocellular carcinoma. J Dig Dis 2014;15:444-450.
38.
Teo JY, Allen JC Jr, Ng DC, Choo SP, Tai DW, Chang JP, Cheah FK, Chow PK, Goh BK: A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with y90. HPB (Oxford) 2016;18:7-12.
39.
van Lienden KP, van den Esschert JW, de Graaf W, Bipat S, Lameris JS, van Gulik TM, van Delden OM: Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol 2013;36:25-34.
40.
Giraudo G, Greget M, Oussoultzoglou E, Rosso E, Bachellier P, Jaeck D: Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery 2008;143:476-482.
41.
Bhattacharjya S, Gunson BK, Mirza DF, Mayer DA, Buckels JA, McMaster P, Neuberger JM: Delayed hepatic artery thrombosis in adult orthotopic liver transplantation - a 12-year experience. Transplantation 2001;71:1592-1596.
42.
Chapman WC, Halevy A, Blumgart LH, Benjamin IS: Postcholecystectomy bile duct strictures. Management and outcome in 130 patients. Arch Surg 1995;130:597-602; discussion 602-594.
43.
Davidoff AM, Pappas TN, Murray EA, Hilleren DJ, Johnson RD, Baker ME, Newman GE, Cotton PB, Meyers WC: Mechanisms of major biliary injury during laparoscopic cholecystectomy. Ann Surg 1992;215:196-202.
44.
Deziel DJ, Millikan KW, Economou SG, Doolas A, Ko ST, Airan MC: Complications of laparoscopic cholecystectomy: a national survey of 4,292 hospitals and an analysis of 77,604 cases. Am J Surg 1993;165:9-14.
45.
Mathisen O, Soreide O, Bergan A: Laparoscopic cholecystectomy: bile duct and vascular injuries: management and outcome. Scand J Gastroenterol 2002;37:476-481.
46.
Nishio H, Kamiya J, Nagino M, Uesaka K, Kanai M, Sano T, Hiramatsu K, Nimura Y: Right hepatic lobectomy for bile duct injury associated with major vascular occlusion after laparoscopic cholecystectomy. J Hepatobiliary Pancreat Surg 1999;6:427-430.
47.
Sicklick JK, Camp MS, Lillemoe KD, Melton GB, Yeo CJ, Campbell KA, Talamini MA, Pitt HA, Coleman J, Sauter PA, Cameron JL: Surgical management of bile duct injuries sustained during laparoscopic cholecystectomy: perioperative results in 200 patients. Ann Surg 2005;241:786-792; discussion 793-785.
48.
Stewart L, Robinson TN, Lee CM, Liu K, Whang K, Way LW: Right hepatic artery injury associated with laparoscopic bile duct injury: incidence, mechanism, and consequences. J Gastrointest Surg 2004;8:523-530; discussion 530-521.
49.
Halasz NA: Cholecystectomy and hepatic artery injuries. Arch Surg 1991;126:137-138.
50.
Sheldon GF, Rutledge R: Hepatic trauma. Adv Surg 1989;22:179-193.
51.
Koffron A, Ferrario M, Parsons W, Nemcek A, Saker M, Abecassis M: Failed primary management of iatrogenic biliary injury: Incidence and significance of concomitant hepatic arterial disruption. Surgery 2001;130:722-728; discussion 728-731.
52.
Majno PE, Pretre R, Mentha G, Morel P: Operative injury to the hepatic artery. Consequences of a biliary-enteric anastomosis and principles for rational management. Arch Surg 1996;131:211-215.
53.
Strasberg SM, Hertl M, Soper NJ: An analysis of the problem of biliary injury during laparoscopic cholecystectomy. J Am Coll Surg 1995;180:101-125.
54.
Kishi K, Sonomura T, Satoh M, Nishida N, Terada M, Shioyama Y, Yamada R: Acute toxicity of lipiodol infusion into the hepatic arteries of dogs. Invest Radiol 1994;29:882-889.
55.
Doppman JL, Girton M, Kahn R: Proximal versus peripheral hepatic artery embolization experimental study in monkeys. Radiology 1978;128:577-588.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.